ResearcherRush University Medical CenterActive in the last 2 years
Eileena F. Giurini
Matched on ORCID iD 0009-0000-9141-5276; OpenAlex author ID A5084893492. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2024: 1 paper · 2025: 1 paper
Papers 2
- Looking Beyond Checkpoint Inhibitor Monotherapy: Uncovering New Frontiers for Pancreatic Cancer Immunotherapy. Co-author DOI 10.1158/1535-7163.mct-24-0311↗
- Tetanus Toxoid Utilizes Dual-Faceted Anticancer Mechanism Through Targeting Tumoral Sialic Acids and Enhancing Cytotoxic CD4+ T cell Responses Against Pancreat… Co-author DOI 10.1101/2024.11.19.624337↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kajal H. Gupta · 2 shared papers, 2024–2025 · strength 0.73
- Paper Looking Beyond Checkpoint Inhibitor Monotherapy: Uncovering New Frontiers for Pancreatic Cancer Immunotherapy. DOI 10.1158/1535-7163.mct-24-0311↗
- Paper Tetanus Toxoid Utilizes Dual-Faceted Anticancer Mechanism Through Targeting Tumoral Sialic Acids and Enhancing Cytotoxi… DOI 10.1101/2024.11.19.624337↗
- Sam G. Pappas · 2 shared papers, 2024–2025 · strength 0.73
- Paper Looking Beyond Checkpoint Inhibitor Monotherapy: Uncovering New Frontiers for Pancreatic Cancer Immunotherapy. DOI 10.1158/1535-7163.mct-24-0311↗
- Paper Tetanus Toxoid Utilizes Dual-Faceted Anticancer Mechanism Through Targeting Tumoral Sialic Acids and Enhancing Cytotoxi… DOI 10.1101/2024.11.19.624337↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.